These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17221016)

  • 1. Dopamine dysregulation syndrome in Parkinson's disease: case report.
    Kummer A; Maia DP; Salgado JV; Cardoso FE; Teixeira AL
    Arq Neuropsiquiatr; 2006 Dec; 64(4):1019-22. PubMed ID: 17221016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dopamine dysregulation syndrome in a patient with Parkinson's disease; a case report].
    Hol WM; van der Zwaard R; Hovestadt A; van Megen HJ
    Tijdschr Psychiatr; 2010; 52(4):259-63. PubMed ID: 20503167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.
    Nissenbaum H; Quinn NP; Brown RG; Toone B; Gotham AM; Marsden CD
    Psychol Med; 1987 Nov; 17(4):899-904. PubMed ID: 3432464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insidious dopamine: provocateur or protective agent in Parkinson's disease?
    Kostrzewa RM; Brus R; Kostrzewa JP
    Pol J Pharmacol; 2001; 53(2):165-6. PubMed ID: 11787956
    [No Abstract]   [Full Text] [Related]  

  • 6. Levodopa for the treatment of Parkinson's disease.
    Lewitt PA
    N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127
    [No Abstract]   [Full Text] [Related]  

  • 7. Addiction as aberrant learning-evidence from Parkinson's disease.
    Dagher A
    Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
    [No Abstract]   [Full Text] [Related]  

  • 8. Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?
    Coon EA; Laughlin RS
    J Headache Pain; 2012 Apr; 13(3):255-7. PubMed ID: 22322657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease.
    Ricciardi L; Espay KJ; Krikorian R; Fasano A; Espay AJ
    Parkinsonism Relat Disord; 2016 Jul; 28():152-4. PubMed ID: 27086263
    [No Abstract]   [Full Text] [Related]  

  • 10. Case study: cerebrovascular parkinsonism with levodopa addiction.
    Lily O; Al-Din A
    J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1365-6. PubMed ID: 15314141
    [No Abstract]   [Full Text] [Related]  

  • 11. Lees' syndrome: a case series.
    Becker N; Munhoz RP; Teive HA
    Arq Neuropsiquiatr; 2011 Oct; 69(5):756-9. PubMed ID: 22042176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine dysregulation syndrome in Parkinson's disease patients on duodenal levodopa infusion.
    Cannas A; Solla P; Marrosu MG; Marrosu F
    Mov Disord; 2013 Jun; 28(6):840-1. PubMed ID: 23801562
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropsychiatric effects of Parkinson's disease treatment.
    Aarons S; Peisah C; Wijeratne C
    Australas J Ageing; 2012 Sep; 31(3):198-202. PubMed ID: 22950594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of bipolar disorder, dopamine dysregulation syndrome, and punding in Brazilian patients with Parkinson's disease.
    Kummer A; Dias FM; Cardoso F; Teixeira AL
    Braz J Psychiatry; 2010 Mar; 32(1):62-5. PubMed ID: 20339736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.
    Benincasa D; Pellicano C; Fanciulli A; Pontieri FE
    Mov Disord; 2011 Feb; 26(2):355-7. PubMed ID: 21412840
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline may be toxic in presence of increased dopamine concentrations.
    Yu PH; Lai CT; Boulton AA
    BMJ; 1996 Mar; 312(7032):703-4; author reply 704-5. PubMed ID: 8597749
    [No Abstract]   [Full Text] [Related]  

  • 17. [Levodopa dependency in Parkinson's disease: case report and review].
    Müller U; Reuter M; Hermann W; Gertz HJ
    Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-related motor complications--phenomenology.
    Fox SH; Lang AE
    Mov Disord; 2008; 23 Suppl 3():S509-14. PubMed ID: 18781677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
    Merims D; Giladi N
    Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
    Evans AH; Katzenschlager R; Paviour D; O'Sullivan JD; Appel S; Lawrence AD; Lees AJ
    Mov Disord; 2004 Apr; 19(4):397-405. PubMed ID: 15077237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.